Diffuse panbronchiolitis in East Asia (Q33844946)

29 July 2017

1 reference

title

Diffuse panbronchiolitis in East Asia (English)

1 reference

29 July 2017

main subject

diffuse panbronchiolitis

1 reference

Arata Azuma

1

1 reference

29 July 2017

Shoji Kudoh

series ordinal

2

1 reference

29 July 2017

publication date

1 May 2006

1 reference

29 July 2017

1 reference

29 July 2017

volume

11

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

249-261

1 reference

Diffuse panbronchiolitis in the United States

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

A case of diffuse panbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Diffuse panbronchiolitis in Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Diffuse panbronchiolitis in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Analysis of HLA antigens in patients with diffuse panbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Association of HLA class I antigens with diffuse panbronchiolitis in Korean patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Fine localization of a major disease-susceptibility locus for diffuse panbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Delta F508 mutation of cystic fibrosis gene is not found in chronic bronchitis with severe obstruction in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Genetic variations in the 5-lipoxygenase core promoter. Description and functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

The human ATP-binding cassette (ABC) transporter superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Promoter analysis and aberrant expression of the MUC5B gene in diffuse panbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Diffuse panbronchiolitis: diagnosis and distinction from various pulmonary diseases with centrilobular interstitial foam cell accumulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Small airways diseases: detection and insights with computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

The long term chemotherapy with erythromycin in chronic lower respiratory tract infections--first report: comparison with amoxicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Centrilobular nodules correlate with air trapping in diffuse panbronchiolitis during erythromycin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Phenotypic characterization of T cells in bronchoalveolar lavage fluid (BALF) and peripheral blood of patients with diffuse panbronchiolitis; the importance of cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Effects of sub-MICs of erythromycin and other macrolide antibiotics on serum sensitivity of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Oral erythromycin and the risk of sudden death from cardiac causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Association of HLA class I antigen deficiency related to a TAP2 gene mutation with familial bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Diffuse panbronchiolitis: evaluation with high-resolution CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Diffuse panbronchiolitis: correlation of high-resolution CT and pathologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Diffuse panbronchiolitis: follow-up CT examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

[The long term chemotherapy with erythromycin in chronic lower respiratory tract infections--second report: including cases with Pseudomonas infections]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Long-term chemotherapy using erythromycin (EM) for chronic lower airway infection: effectiveness of clarithromycin in EM ineffective cases--the fourth report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Erythromycin promotes monocyte to macrophage differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

'Subinhibitory' erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Separation and detection of macrolide antibiotics by HPLC using macrolide-imprinted synthetic polymers as stationary phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Macrolides with gastrointestinal motor stimulating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

Securing the safety and efficacy of macrolide therapy for chronic small airway diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00845.X

10.1111/J.1440-1843.2006.00845.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference